Cargando…

Relevance of (18)F-DOPA visual and semi-quantitative PET metrics for the diagnostic of Parkinson disease in clinical practice: a machine learning-based inference study

PURPOSE: To decipher the relevance of visual and semi-quantitative 6-fluoro-(18F)-L-DOPA ((18)F-DOPA) interpretation methods for the diagnostic of idiopathic Parkinson disease (IPD) in hybrid positron emission tomography (PET) and magnetic resonance imaging. MATERIAL AND METHODS: A total of 110 cons...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iep, Alex, Chawki, Mohammad B., Goldfarb, Lucas, Nguyen, Loc, Brulon, Vincent, Comtat, Claude, Lebon, Vincent, Besson, Florent L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9925664/ https://www.ncbi.nlm.nih.gov/pubmed/36780091 http://dx.doi.org/10.1186/s13550-023-00962-x

Ejemplares similares

PET Molecular Imaging: A Holistic Review of Current Practice and Emerging Perspectives for Diagnosis, Therapeutic Evaluation and Prognosis in Clinical Oncology
por: Duclos, Valentin, et al.
Publicado: (2021)

Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
por: Pikstra, Angelina R.A., et al.
Publicado: (2016)

(18)F-FDG PET and DCE kinetic modeling and their correlations in primary NSCLC: first voxel-wise correlative analysis of human simultaneous [18F]FDG PET-MRI data
por: Besson, Florent L., et al.
Publicado: (2020)

Towards an Automated Approach to the Semi-Quantification of [(18)F]F-DOPA PET in Pediatric-Type Diffuse Gliomas
por: Peira, Enrico, et al.
Publicado: (2023)

Parkinson’s disease multimodal imaging: F-DOPA PET, neuromelanin-sensitive and quantitative iron-sensitive MRI
por: Depierreux, Frédérique, et al.
Publicado: (2021)

The Dopamine Augmenter L-DOPA Does Not Affect Positive Mood in Healthy Human Volunteers
por: Liggins, John, et al.
Publicado: (2012)

Dopa Responsive Slow Orthostatic Tremor in Parkinson’s Disease
por: Lee, Suk Yoon, et al.
Publicado: (2011)

Molecular Effects of L-dopa Therapy in Parkinson’s Disease
por: Dorszewska, Jolanta, et al.
Publicado: (2014)

Beyond L-DOPA: hope for Parkinson’s treatment and diagnosis
Publicado: (2017)

Predictors of Levo-dopa induced Dyskinesias in Parkinson's Disease
por: Athulya, RT, et al.
Publicado: (2020)

L-DOPA-therapy in Parkinson’s disease: some personal reflections on L-DOPA therapy from Vienna and Berlin
por: Riederer, Peter, et al.
Publicado: (2023)

Relevance of Dynamic (18)F-DOPA PET Radiomics for Differentiation of High-Grade Glioma Progression from Treatment-Related Changes
por: Ahrari, Shamimeh, et al.
Publicado: (2021)

Parkinson’s disease, L-DOPA, and endogenous morphine: A revisit
por: Stefano, George B., et al.
Publicado: (2012)

DOPA-sparing strategy in the treatment of young onset Parkinson's disease
por: Rana, Abdul Qayyum, et al.
Publicado: (2016)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Is DOPA-Responsive Hypokinesia Responsible for Bimanual Coordination Deficits in Parkinson’s Disease?
por: Almeida, Quincy J., et al.
Publicado: (2013)

Altered cerebellar connectivity in Parkinson's patients ON and OFF L-DOPA medication
por: Festini, Sara B., et al.
Publicado: (2015)

Novel GCH1 variant in Dopa-responsive dystonia and Parkinson's disease
por: Lewthwaite, A.J., et al.
Publicado: (2015)

Orbitofrontal (18)F-DOPA Uptake and Movement Preparation in Parkinson's Disease
por: Marinelli, Lucio, et al.
Publicado: (2015)

The Design and Evaluation of an l-Dopa–Lazabemide Prodrug for the Treatment of Parkinson’s Disease
por: Hoon, Monique, et al.
Publicado: (2017)

Inhaling xenon ameliorates l‐dopa‐induced dyskinesia in experimental parkinsonism
por: Baufreton, Jérôme, et al.
Publicado: (2018)

Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson’s Disease
por: Bello, Fabio Del, et al.
Publicado: (2019)

Normal biodistribution pattern and physiologic variants of (18)F-DOPA PET imaging
por: Chondrogiannis, Sotirios, et al.
Publicado: (2013)

L-DOPA
por: Hornykiewicz, Oleh
Publicado: (2017)

An Integrative Approach to Treat Parkinson's Disease: Ukgansan Complements L-Dopa by Ameliorating Dopaminergic Neuronal Damage and L-Dopa-Induced Dyskinesia in Mice
por: Huh, Eugene, et al.
Publicado: (2019)

Novel anti-apoptotic L-DOPA precursors SuperDopa and SuperDopamide as potential neuroprotective agents for halting/delaying progression of Parkinson’s disease
por: Wiesen, Tom, et al.
Publicado: (2022)

Caffeine reduces deficits in mechanosensation and locomotion induced by L-DOPA and protects dopaminergic neurons in a transgenic Caenorhabditis elegans model of Parkinson’s disease
por: Manalo, Rafael Vincent M., et al.
Publicado: (2020)

Readiness Potential in Parkinson's Disease: Effects of L-Dopa Therapy and Brain Transplants
por: Martínez, D. N. Velázquez, et al.
Publicado: (1992)

Advances in Neurology, Volume 2. Treatment of Parkinsonism—The Role of Dopa Decarboxylase Inhibitors
por: Pincus, Jonathan H.
Publicado: (1974)

The role of GRK6 in animal models of Parkinson's Disease and L-DOPA treatment
por: Managò, Francesca, et al.
Publicado: (2012)

Pilot study of atomoxetine in patients with Parkinson’s disease and dopa-unresponsive Freezing of Gait
por: Revuelta, Gonzalo J., et al.
Publicado: (2015)

L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson’s Disease
por: Blosser, Joshua A., et al.
Publicado: (2020)

Individual Magnetoencephalography Response Profiles to Short-Duration L-Dopa in Parkinson’s Disease
por: Peña, Edgar, et al.
Publicado: (2021)

Differences in Brain Activity Between Dopa-Responsive and -Unresponsive Pain in Parkinson’s Disease
por: Zheng, Jin Hua, et al.
Publicado: (2022)

In situ continuous Dopa supply by responsive artificial enzyme for the treatment of Parkinson’s disease
por: Fang, Xiao, et al.
Publicado: (2023)

(18)F-FDG PET molecular imaging: A relevant tool to investigate chronic inflammatory rheumatisms in clinical practice?
por: Pean De Ponfilly – Sotier, Marie, et al.
Publicado: (2022)

Determinants of treatment response in first-episode psychosis: an (18)F-DOPA PET study
por: Jauhar, Sameer, et al.
Publicado: (2018)

Regulation of dopaminergic function: an [(18)F]-DOPA PET apomorphine challenge study in humans.
por: Jauhar, S, et al.
Publicado: (2017)

Distinct amyloid and tau PET signatures are associated with diverging clinical and imaging trajectories in patients with amnestic syndrome of the hippocampal type
por: Lagarde, Julien, et al.
Publicado: (2021)

A systematic literature review of cyber-security data repositories and performance assessment metrics for semi-supervised learning
por: Mvula, Paul K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jcdcotmc2tk0ae8c0mv3g0divi